Xarelto vs Lisinopril
A side-by-side look at two cardiovascular medications advertised on TV. Informational only — not medical advice.
| US Xarelto | US Lisinopril | |
|---|---|---|
| Generic name | rivaroxaban | lisinopril |
| Drug class | Factor Xa Inhibitor | ACE Inhibitor |
| Treats | Blood clots, atrial fibrillation | High blood pressure, heart failure |
| Category | Cardiovascular | Cardiovascular |
| Manufacturer | Janssen/Bayer | Various (generic) |
| Year approved | 2011 | 1987 |
| FDA warning | Black box warning | Black box warning |
| Est. TV ad spend | $210M | $1M |
| Common side effects | Serious bleeding risk, Bruising, Prolonged bleeding, Spinal/epidural blood clots | Dry cough, Dizziness, High potassium, Headache |
Lisinopril
Frequently asked questions
Is Xarelto or Lisinopril better?
Neither is universally "better." Xarelto (rivaroxaban) and Lisinopril (lisinopril) are both used for cardiovascular, but the right choice depends on your medical history, insurance and your doctor's guidance. This comparison is informational only.
What's the difference between Xarelto and Lisinopril?
Xarelto is a Factor Xa Inhibitor made by Janssen/Bayer, while Lisinopril is a ACE Inhibitor made by Various (generic). See the table above for a side-by-side breakdown.
Which one spends more on TV ads?
Xarelto has the larger estimated TV advertising budget of the two.